Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...

The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...

A high omega-3, low omega-6 diet with fish oil reduced the prostate Ki-67 index by 15% in prostate cancer patients. The CAPFISH-3 trial involved 100 men on active surveillance for grade group 1 or 2 ...

We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk prostate cancer. This phase III, single ...

Joe Biden’s recent diagnosis of "aggressive" prostate cancer has sparked concerns about how far the disease has advanced. The former president’s prostate cancer has been characterized by a Gleason ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

In a population-based study, patients with lower urinary tract symptoms (LUTS) or urinary tract infections (UTIs) were more than fourfold more likely to undergo prostate biopsy but showed 44% lower ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

ALERT. REACTION AND SUPPORT HAVE BEEN POURING IN FOLLOWING FORMER PRESIDENT JOE BIDEN’S PROSTATE CANCER DIAGNOSIS. AND THIS MORNING, SO IS AN EFFORT TO RAISE AWARENESS. LET’S LOOK AT THE NUMBERS.

Former US President Joe Biden has been diagnosed with an “aggressive” form of prostate cancer, according to a statement released by his office on May 18. “Last week, President Joe Biden was seen for a ...